Header cover image

U.S. Drug Retail Industry Analysis

UpdatedMay 27, 2025
DataAggregated Company Financials
Companies11
  • 7D-3.2%
  • 3M-0.7%
  • 1Y-30.6%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 2.2%, driven by a pullback from Guardian Pharmacy Services of 17%. Meanwhile, Mangoceuticals actually outperformed within the industry, gaining 12% in the last week. Overall the industry is down 31% in 12 months. Looking forward, earnings are forecast to grow by 89% annually.

Industry Valuation and Performance

Has the U.S. Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 27 May 2025US$11.2bUS$155.4b-US$5,907,878,938.64n/a-1.9x0.07x
Thu, 24 Apr 2025US$11.1bUS$155.3b-US$5,913,772,559.02n/a-1.9x0.07x
Sat, 22 Mar 2025US$11.1bUS$153.7b-US$8,956,826,121.26n/a-1.2x0.07x
Mon, 17 Feb 2025US$9.7bUS$153.8b-US$8,983,704,364.05n/a-1.1x0.06x
Wed, 15 Jan 2025US$11.9bUS$153.8b-US$8,981,980,995.07n/a-1.3x0.08x
Fri, 13 Dec 2024US$10.1bUS$151.0b-US$8,784,282,314.55n/a-1.2x0.07x
Sun, 10 Nov 2024US$9.3bUS$151.0b-US$8,683,283,565.3995.9x-1.1x0.06x
Tue, 08 Oct 2024US$8.9bUS$148.9b-US$5,859,336,868.2477.5x-1.5x0.06x
Thu, 05 Sep 2024US$7.8bUS$147.8b-US$5,892,380,347.14n/a-1.3x0.05x
Sat, 03 Aug 2024US$10.3bUS$147.8b-US$5,889,025,690.14n/a-1.8x0.07x
Mon, 01 Jul 2024US$10.6bUS$147.8b-US$5,905,480,990.57n/a-1.8x0.07x
Wed, 29 May 2024US$14.0bUS$146.9b-US$6,130,739,410.0038.5x-2.3x0.1x
Fri, 26 Apr 2024US$15.3bUS$146.9b-US$6,142,334,632.2938.5x-2.5x0.1x
Sun, 24 Mar 2024US$17.9bUS$144.7bUS$486.4m30.9x36.8x0.1x
Tue, 20 Feb 2024US$19.2bUS$144.7bUS$499.5m33x38.4x0.1x
Thu, 18 Jan 2024US$19.3bUS$144.7bUS$445.0m33.8x43.4x0.1x
Sat, 16 Dec 2023US$22.0bUS$141.4b-US$3,209,435,173.0044.1x-6.8x0.2x
Mon, 13 Nov 2023US$18.2bUS$164.8b-US$4,853,574,614.0067.3x-3.8x0.1x
Wed, 11 Oct 2023US$19.7bUS$138.4b-US$3,448,576,055.00361.3x-5.7x0.1x
Fri, 08 Sep 2023US$19.4bUS$138.4b-US$3,448,394,091.00361.3x-5.6x0.1x
Sun, 06 Aug 2023US$26.2bUS$138.3b-US$3,450,861,037.00361.3x-7.6x0.2x
Tue, 04 Jul 2023US$25.4bUS$138.3b-US$3,448,595,044.00n/a-7.4x0.2x
Thu, 01 Jun 2023US$26.1bUS$135.5b-US$3,271,877,306.00n/a-8x0.2x
Sat, 29 Apr 2023US$30.7bUS$135.5b-US$3,266,589,897.00n/a-9.4x0.2x
Mon, 27 Mar 2023US$28.5bUS$134.4b-US$3,078,179,619.00n/a-9.3x0.2x
Wed, 22 Feb 2023US$31.5bUS$134.3b-US$3,076,595,997.00n/a-10.2x0.2x
Fri, 20 Jan 2023US$30.8bUS$134.3b-US$3,077,451,396.00n/a-10x0.2x
Sun, 18 Dec 2022US$34.0bUS$134.7bUS$4.2b7.8x8x0.3x
Tue, 15 Nov 2022US$35.4bUS$134.7bUS$4.2b8.1x8.4x0.3x
Thu, 13 Oct 2022US$27.9bUS$136.5bUS$5.0b5.4x5.6x0.2x
Sat, 10 Sep 2022US$31.7bUS$136.6bUS$5.0b6.1x6.4x0.2x
Mon, 08 Aug 2022US$34.0bUS$136.6bUS$5.0b6.6x6.8x0.2x
Wed, 06 Jul 2022US$33.6bUS$136.6bUS$5.0b6.5x6.8x0.2x
Fri, 03 Jun 2022US$37.6bUS$138.0bUS$5.8b6.3x6.5x0.3x
Price to Earnings Ratio

6.5x


Total Market Cap: US$37.6bTotal Earnings: US$5.8bTotal Revenue: US$138.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Drug Retail Industry Price to Earnings3Y Average 1.4x202320242025
Current Industry PE
  • Investors are pessimistic on the American Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading close to its 3-year average PS ratio of 0.15x.
Past Earnings Growth
  • Total earnings for the Drug Retail industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 4.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Drug Retail compare with similar industries?

US Market-2.65%
Consumer Staples-1.37%
Food and Staples Retail-1.94%
Drug Retail-3.16%
Food Retail-1.00%
Big Box Super Stores-1.98%
Food Distributors-2.45%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MGRX MangoceuticalsUS$1.697.0%
+US$1.2m
-74.4%PS36.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GRDN

US$21.94

Guardian Pharmacy Services

7D

-17.2%

1Y

n/a

MGRX

US$1.69

Mangoceuticals

7D

7.0%

1Y

-74.4%

WBA

US$11.17

Walgreens Boots Alliance

7D

-0.5%

1Y

-27.4%

RDGT

US$0.97

Ridgetech

7D

-6.2%

1Y

-65.9%

YI

US$7.93

111

7D

-0.6%

1Y

-37.6%